CIK 0000921299 · Non-accelerated filer<br>Smaller reporting company
KYNTRA BIO, INC.
Sign in to watch- Ticker
- KYNB
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Entity type
- operating
- EIN
- 770357827
- Phone
- 415-978-1200
- Business address
- 350 BAY STREET, SUITE 100 #6009, SAN FRANCISCO, CA, 94133
- Former names
- FIBROGEN INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2025-09-06 | Wettig Thane CEO | Shares withheld for taxes | −248 | $12.10 | $3K | 21,239 |
| 2025-06-30 | Schoeneck James A Director | Purchase | +23,567 | $5.07 | $119K | 39,666 |
| 2025-06-06 | DeLucia David Chief Financial Officer | Shares withheld for taxes | −51 | $7.83 | $399 | 4,594 |
| 2025-06-06 | Wettig Thane CEO | Shares withheld for taxes | −246 | $7.83 | $2K | 21,487 |
| 2025-06-04 | Ho Maykin Director | Grant or award · Stock Option (Right to Buy) | +120,000 | 120,000 | ||
| 2025-06-04 | EDWARDS JEFFREY L Director | Grant or award · Stock Option (Right to Buy) | +120,000 | 120,000 | ||
| 2025-06-04 | Schoeneck James A Director | Grant or award · Stock Option (Right to Buy) | +120,000 | 120,000 | ||
| 2025-06-04 | Kauffman Michael Director | Grant or award · Stock Option (Right to Buy) | +70,000 | 70,000 | ||
| 2025-06-04 | Kauffman Michael Director | Grant or award · Stock Option (Right to Buy) | +120,000 | 120,000 | ||
| 2025-03-24 | Wettig Thane CEO | Purchase | +145,000 | $0.35 | $51K | 543,329 |
| 2025-03-21 | Schoeneck James A Director | Purchase | +50,000 | $0.34 | $17K | 373,722 |
| 2025-03-20 | Schoeneck James A Director | Purchase | +250,000 | $0.35 | $88K | 323,722 |
| 2025-03-06 | Wettig Thane CEO | Shares withheld for taxes | −22,038 | $0.39 | $9K | 397,915 |
| 2025-03-06 | Wettig Thane CEO | Grant or award | +781 | 398,696 | ||
| 2025-03-06 | Wettig Thane CEO | Shares withheld for taxes | −367 | $0.39 | $143 | 398,329 |
| 2025-03-06 | Chung Christine SVP, CHINA OPERATIONS | Shares withheld for taxes | −7,008 | $0.39 | $3K | 294,544 |
| 2025-03-06 | Chung Christine SVP, CHINA OPERATIONS | Grant or award | +781 | 295,325 | ||
| 2025-03-06 | Chung Christine SVP, CHINA OPERATIONS | Shares withheld for taxes | −422 | $0.39 | $165 | 294,903 |
| 2025-03-06 | DeLucia David Chief Financial Officer | Shares withheld for taxes | −2,325 | $0.39 | $907 | 116,137 |
| 2025-01-09 | DeLucia David Chief Financial Officer | Grant or award · Stock Option (Right to Buy) | +525,000 | 525,000 |
Page 2 of 8 · 156 trades